Overview

VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Study hypothesis: High-dose vitamin D leads to a shorter hospital stay in critically ill patients Vitamin D deficient patients will be randomized to receive either 540,000 IU cholecalciferol or placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Harald Dobnig, MD
Treatments:
Cholecalciferol
Vitamin D